Karl‐Georg Simon

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Thomas Berg, Karl‐Georg Simon, Stefan Mauss et al. · Journal of Hepatology · 2017 · 313 citations

Pharmacy, Pharmacology, Pharmacotherapy +4

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Julia Dietz, S. Süsser, Johannes Vermehren et al. · Gastroenterology · 2017 · 151 citations

Life Sciences, Infectious Diseases, Microbiology +16

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Florian van Bömmel, Kerstin Stein, R Heyne et al. · Journal of Hepatology · 2023 · 92 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Patrick Ingiliz, Stefan Christensen, Torben Kimhofer et al. · Clinical Infectious Diseases · 2016 · 73 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Patrick Ingiliz, Malte H. Wehmeyer, Christoph Boesecke et al. · Clinical Infectious Diseases · 2019 · 71 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +17